ENYO Pharma SA
BIOSERRA 1 Bâtiment B
60 avenue Rockefeller
69008 LYON, FRANCE
+33 (0)4 37 70 02 19
SIREN: 799 831 011 RCS Lyon
Publishing Director: Jacky Vonderscher, CEO
Hosting is provided by iilyo SAS
Address: 33, place bellecour, 69002 Lyon, FRANCE
No warranty and no liability
While ENYO Pharma SA is making best efforts to include accurate and up-to-date information, we make no representations or warranties, express or implied, as to the accuracy or completeness of the information provided on this Website and disclaim any liability for the use of this site or any site linked to it. ENYO Pharma SA may change this site at any time without notice but does not assume any responsibility to update it. Neither ENYO Pharma SA nor any other party involved in creating, producing or delivering this Website or on any Website linked to from this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Website or any Website linked to from this site, or any errors or omissions in the content thereof.
This page may contain forward-looking information and estimates with respect to ENYO Pharma’s clinical trials, clinical trial data releases, clinical development plans and anticipated future activities of ENYO Pharma. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will” and “continue” and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management’s beliefs.. Such information is subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented. There can be no guarantees with respect to pipeline product candidates that the clinical trial results will be available on their anticipated timeline, that future clinical trials will be initiated as anticipated, or that candidates will receive the necessary regulatory approvals. Given these risks and uncertainties, no representations are made as to the accuracy or fairness of such forward-looking statements, forecasts and estimates. Furthermore, forward-looking statements, forecasts and estimates only speak as of the date of their disclosure. Readers are cautioned not to place undue reliance on any of these forward-looking statement.
Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.
All mentioned trademarks are owned by or licensed to ENYO Pharma SA. Use of the trademarks owned by ENYO Pharma SA and/or its products without prior authorization is prohibited.
The Website of ENYO Pharma SA and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited. Request for permission to reproduce any information contained on this Website should be addressed to ENYO Pharma SA.